Abnormal tissue oxygenation and cardiovascular changes in endotoxemia

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 1710-1715

  Anning, Peter B ^a   Sair, Mark ^a   Winlove, C Peter ^a   Evans, Timothy W ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INHIBITION; FLUID THERAPY; HEMODYNAMICS; HYPOXEMIA; MALE; METABOLIC ACIDOSIS; MICROCIRCULATION; MICROELECTRODE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TISSUE OXYGENATION;

EID: 0033064174     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9801124     Document Type: Article

References (32)

1. 1. Centers for Disease Control. 1990. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987. M.M.W.R. 39:31-34.
2. 2. St. John, R. C. and P. M. Dorinsky. 1994. An overview of multiple organ dysfunction syndrome. J. Lab. Clin. Med. 124:478-483.
3. 3. Myers, P. R., Q. Zhong, J. J. Jones, M. A. Tanner, H. R. Adams, and J. L. Parker. 1995. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am. J. Physiol. 268: H955-H961.
4. 4. Curzen, N. P., M. J. Griffiths, and T. W. Evans. 1994. Role of the endothelium in modulating the vascular response to sepsis [Editorial]. Clin. Sci. Colch. 86:359-374.
5. 5. Bunnell, E., and J. E. Parrillo. 1996. Cardiac dysfunction during septic shock. Clin. Chest Med. 17:237-248.
6. 6. Payen, D., C. Bernard, and S. Beloucif. 1996. Nitric oxide in sepsis. Clin. Chest Med. 17:333-350.
7. 7. Liu, S., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. 1993. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196:1208-1213.
8. 8. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock [see comments]. Lancet 338:1557-1558.
9. 9. Griffiths, M. J., N. P. Curzen, M. Sair, and T. W. Evans. 1994. Nitric oxide synthase inhibitors in septic shock: theoretical considerations. Clin. Int. Care 5:29-36.
10. 10. Sair, M., P. J. Etherington, N. P. Curzen, C. P. Winlove, and T. W. Evans. 1996. Tissue oxygenation and perfusion in endotoxemia. Am. J. Physiol. 271:H1620-H1625.
11. 11. Fink, M. P. 1996. Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med. 22:1144-1146.
12. 12. Kopp, K. H., E. Sinagowitz, and H. Muller. 1984. Oxygen supply of skeletal muscle in experimental endotoxic shock. Adv. Exp. Med. Biol. 169:467-476.
13. 2 during hypodynamic sepsis. Chest 99:224-229.
14. 14. Rosser, D. M., R. P. Stidwill, D. Jacobson, and M. Singer. 1995. Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J. Appl. Physiol. 79:1878-1882.
15. 15. Reinhart, K., F. Bloos, F. Konig, L. Hannemann, and B. Kuss. 1990. Oxygen transport variables and muscle tissue oxygenation in critically ill patients with and without sepsis. Adv. Exp. Med. Biol. 277:861-864.
16. 16. Boekstegers, P., S. Weidenhofer, T. Kapsner, and K. Werdan. 1994. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit. Care Med. 22:640-650.
17. 17. Lund, N., R. J. de Asla, F. Cladis, P. J. Papadakos, and P. A. Thorborg. 1995. Dopexamine hydrochloride in septic shock: effects on oxygen delivery and oxygenation of gut, liver, and muscle. J. Trauma 38:767-775.
18. 18. Astiz, M., E. C. Rackow, M. H. Weil, and W. Schumer. 1988. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ. Shock 26:311-320.
19. 19. Vallet, B., S. E. Curtis, M. J. Winn, C. E. King, C. K. Chapler, and S. M. Cain. 1994. Hypoxic vasodilation does not require nitric oxide (EDRF/NO) synthesis. J. Appl. Physiol. 76:1256-1261.
20. 20. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
21. 21. Liu, S. F., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. 1994. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit. Care Med. 24:1219-1225.
22. 22. Griffiths, M. J., S. Liu, N. P. Curzen, M. Messent, and T. W. Evans. 1995. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am. J. Physiol. 268:L509-L518.
23. 23. Meyer, J., F. Hinder, J. Stothert, Jr., L. D. Traber, D. N. Herndon, J. T. Flynn, and D. L. Traber. 1994. Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J. Appl. Physiol. 76:2785-2793.
24. 24. Teale, D. M., and A. M. Atkinson. 1992. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J. Antimicroh. Chemother. 30:839-842.
25. 2 uptake after inhibition of EDRF/NO synthesis. J. Appl. Physiol. 76:1166-1171.
26. 26. Saetre, T., O. A. Smiseth, T. Scholz, H. Carlsen, L. Nordsletten, E. Fahlstrom, and A. O. Aasen. 1996. Nitric oxide synthase inhibition reduces venous return in porcine endotoxemia. Am. J. Physiol. 271:H1325-H1332.
27. 27. Spain, D. A., M. A. Wilson, M. F. Bar Natan, and R. N. Garrison. 1994. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J. Trauma 36:720-725.
28. 28. Schumacker, P. T., J. Kazaglis, H. V. Connolly, R. W. Samsel, M. F. O'Connor, and J. G. Umans. 1995. Systemic and gut oxygen extraction during endotoxemia: role of nitric oxide synthesis. Am. J. Respir. Crit. Care Med. 151:107-115.
29. 29. Griffiths, M. J. D., N. P. Curzen, J. A. Mitchell, and T. W. Evans. 1997. In vitro treatment with endotoxin increases rat pulmonary vascular contractility despite NOS induction. Am. J. Respir. Crit. Care Med. 156:654-658.
30. 30. Liu, S. F., D. E. Crawley, P. J. Barnes, and T. W. Evans. 1991. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143:32-37.
31. 31. Wu, C. C., S. J. Chen, C. Szabo, C. Thiemermann, and J. R. Vane. 1995. Br. J. Pharmacol. 114:1666-1672.
32. 32. Liaudet, L., F. Feihl, A. Rosselet, M. Markert, J. M. Hurni, and C. Perret. 1996. Clin. Sci. Colch. 90:369-377.